TITLE

Depressive disorder needs an evidence base commensurate with its public health importance

AUTHOR(S)
Geddes, John R.; Furukawa, Toshi A.; Cipriani, Andrea; Barbui, Corrado
PUB. DATE
September 2007
SOURCE
Canadian Journal of Psychiatry;Sep2007, Vol. 52 Issue 9, p543
SOURCE TYPE
Academic Journal
DOC. TYPE
commentary
ABSTRACT
The article focuses on the views of the authors regarding the efficacy of antidepressants. According to the authors, antidepressants are efficacious in the short term. They opine that long-term therapy of depression with antidepressants can reduce the risk of relapse in patients who have benefited from treatment in the acute phase.
ACCESSION #
26947380

 

Related Articles

  • Pharmacological means to improve patients' mood. Are they effective and safe? Zylicz, Zbigniew Ben // Medycyna Paliatywna w Praktyce;2016, Vol. 10 Issue 4, p155 

    Low mood and depression can be treated with many non-pharmacological means. However, in terminally ill these means are sometimes insufficient and the doctors need to prescribe drugs. In this article I shall discuss simple and proven drugs that improve patients mood and, some of them do have...

  • Combination therapy more effectively induces remission of major depressive disorder.  // JAAPA: Journal of the American Academy of Physician Assistants (;Jun2010, Vol. 23 Issue 6, p53 

    The article reports on a study which found that combination therapy with mirtazapine and other antidepressant medications is more effective than just fluoxetine for achieving remission of major depression.

  • The antidepressant debate. Moncrieff, Joanna // British Journal of Psychiatry;Mar2002, Vol. 180, p193 

    The author reflects on the debate in the medical literature concerning the efficacy of antidepressant drugs. She discloses that several studies and researches had proven already that the intake of antidepressants promote various adverse effect. She particularly regards its impact to depressive...

  • Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]. Kasper, Siegfried; Anghelescu, Ion-George; Szegedi, Armin; Dienel, Angelika; Kieser, Meinhard // BMC Medicine;2006, Vol. 4, p1 

    Background: The aim of the current study was to assess the antidepressant efficacy and safety of Hypericum perforatum (St. John's wort) extract WS® 5570 at doses of 600 mg/day in a single dose and 1200 mg/day in two doses. Methods: The participants in this double-blind, randomized,...

  • Clinical Presentation and Outcome of Geriatric Depression in Subcortical Ischemic Vascular Disease. Bella, R.; Pennisi, G.; Cantone, M.; Palermo, F.; Pennisi, M.; Lanza, G.; Zappia, M.; Paolucci, S. // Gerontology;Apr2010, Vol. 56 Issue 3, p298 

    Background: Vascular damage of frontal-subcortical circuits involved in mood regulation and cognition might be the main contributor to the pathogenesis of late-life depression, and it is linked to poor response to treatment. Objective: To investigate the relationship between executive...

  • The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups. O'Brien, Sinead; McKeon, Patrick; O'Regan, Myra; O'Brien, S; McKeon, P; O'Regan, M // British Journal of Psychiatry;Mar93, Vol. 162, p363 

    Eighty patients admitted to hospital with major depression were randomly allocated to six weeks of treatment with tranylcypromine, amitriptyline, or tranylcypromine and amitriptyline in combination, in a double-blind study. Scores on the HRSD improved significantly in all three groups, but there...

  • The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials. Mallinckrodt, Craig H.; Raskin, Joel; Wohlreich, Madelaine M.; Watkin, John G.; Detke, Michael J. // BMC Psychiatry;2004, Vol. 4, p26 

    Background: A mixed-effects model repeated measures approach (MMRM) was specified as the primary analysis in the Phase III clinical trials of duloxetine for the treatment of major depressive disorder (MDD). Analysis of covariance using the last observation carried forward approach to impute...

  • Citalopram reduced depressive symptoms in coronary artery disease with depression. Lespérance, F.; Frasure-Smith, N.; Koszycki, D. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p68 

    The article presents a study on the effectivity of citalopram and interpersonal psychotherapy in reducing depressive symptoms. Results revealed that citalopram improves the Hamilton Depression Rating Scale and Beck Depression Inventory II scores more than the placebo. It also indicated greater...

  • Antidepressants and skin disease. Newbold, P.C.H. // British Medical Journal (Clinical Research Edition);2/6/1988, Vol. 296 Issue 6619, p379 

    Examines the relationship between chronic skin problems and depression. Use of antidepressants in treating skin diseases; Reduction of skin blood flow using antidepressant drugs; Benefits of doxepin on chronic urticaria and dermatographism patients.

  • When antidepressants don't work. Cowen, Philip // Pulse;2/9/2004, Vol. 64 Issue 6, p45 

    Explains the reasons on the ineffectiveness of antidepressants and how to solve the problem. Administration of the appropriate dosage; Recognition of dose-response curves; Decision of switching to an alternative drug; Consideration of using monoamine oxidase inhibitors; Augmentation strategies.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics